Colchicine for heart disease after stent placement
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests if colchicine, a common anti-inflammatory medicine, can help prevent future heart problems in people who have coronary artery disease and recently had a stent placed. It's for adults with at least one extra risk factor like diabetes, smoking, or high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 45 years old or older.
- You have coronary artery disease and recently had a stent placed (within 5 days).
- You have at least one other risk factor, such as diabetes, current smoking, high blood pressure, or high cholesterol.
- You do not have serious liver, kidney, or nerve problems.
- You are not pregnant, planning to become pregnant, or father a child during the study.
- You are not already taking colchicine or medications that interact with it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a daily low dose of colchicine, a medicine used for inflammation, can help prevent a first heart attack or other heart problems in people who are at higher risk due to their risk factors. If you qualify, you would be assigned to take either colchicine or a placebo (a pill with no active medicine) to see if it helps keep your heart healthy.
This trial tests whether taking colchicine around the time of surgery can reduce bad events after surgery in people at higher heart risk. It focuses on helping prevent complications related to inflammation after an operation.
This trial tests whether adding a special scan to look at the fatty plaque in your arteries can help your doctor decide if you need stronger heart medication to prevent future heart attacks or strokes. If you have moderate blockages and signs of inflammation, you may be able to join.
This study tests whether the drug colchicine can reduce inflammation in people with coronary heart disease who have had a stent placed. It aims to see if colchicine helps improve heart health by lowering inflammation.
This trial tests if giving colchicine early after a heart attack (when a drug-coated stent is placed) can help reduce complications. It looks at short-term benefits for people with Non-STEMI.
This trial is for people who had a heart attack and received a specific type of stent (Orsiro). It tests a combination of a single antiplatelet drug and colchicine to see if it helps prevent future heart problems. Colchicine is a medicine that reduces inflammation and might lower the risk of another heart attack.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.